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Epilepsy is one of the most common serious brain disor-
ders; it knows no age, racial, social class, geographic, or na-
tional boundaries1. Often epilepsy is still seen as a benign con-
dition in which individuals only have seizures. Unfortunately, 
the story is not as simple as it seems. Epilepsy is a malignant 
condition, which has a high rate of premature death com-
pared to the general population2-4. Most of the excess death 
is due to the underlying disease causing epilepsy, and some is 
epilepsy-related, including trauma, suicide, aspiration pneu-
monia, status epilepticus, but mostly due to sudden unex-
pected death in epilepsy (SUDEP) that is a leading cause of 
mortality in epileptics2-4. The lack of findings in autopsy and 
the fact that most cases of SUDEP are not witnessed cause dif-
ficulties with regard to the definitions of SUDEP. It is generally 
defined as a sudden, unexpected, witnessed or not witnessed, 
nontraumatic and non-drowning death in patients with epi-
lepsy, with or without evidence of a seizure and excluding doc-
umented status epilepticus, in which postmortem examination 
does not reveal a toxicological or anatomical cause of death5.
The reported incidence of SUDEP is quite variable, and 
this is largely due to differences in patient populations, study 
design, and the criteria for defining SUDEP4. In fact, results 
from a US population-based study indicate that the risk of 
sudden death in people with epilepsy is estimated to be at 
least 20 times higher than the one of the general population6. 
In general terms, SUDEP is responsible for 7.5 to 17% of all 
deaths in people with epilepsy and it has an incidence among 
adults between 1:500 and 1:1,000 patient-years7. Concerning 
risk factors, several studies have tried for more than ten years 
to find factors predisposing to SUDEP in order to identify 
individuals with particularly high risks. To date, several risk 
factors have been identified such as refractoriness of the ep-
ileptic condition, presence of convulsive seizures, early on-
set of epilepsy, antiepileptic medication (polytherapy with 
antiepileptic drugs), young age, and duration of the seizure 
disorder4,8,9. The cause(s) of SUDEP is(are) still unknown, how-
ever research consistently suggests that the main mechanism 
for SUDEP is autonomic deregulation, i.e., cardiac and respi-
ratory abnormalities during and after seizures4,8-10. 
It is clear that SUDEP is mainly, yet not exclusively, a prob-
lem for people with uncontrolled epilepsy9, but our under-
standing of the best way to prevent it is still incomplete. Strict 
evidence for their effectiveness is still lacking, but epidemio-
logical and observational data seem to suggest some measures 
to minimize the risk of SUDEP, including good seizure control, 
stress reduction, participation in physical activity and sports 
(with appropriate professional supervision), dietary manage-
ment (omega-three supplementation), night supervision, fam-
ily members’ knowledge of cardiopulmonary resuscitation 
techniques, and the basics of defibrillator use9,11,12.
Despite the great scientific advances of SUDEP over the 
past two decades, the discussion of potential death related to 
seizures is still a topic under discussion between epileptolo-
gists. Due to the high sensitivity of the issue, some clinicians 
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abstRact
People with epilepsy are more likely to die prematurely, and the most common epilepsy-related category of death is sudden unexpected 
death in epilepsy (SUDEP). Thus, the purpose of this article was to alert the scientific community about SUDEP.
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Resumo
Pessoas com epilepsia têm maior chance de morrer prematuramente e a principal causa de morte relacionada à epilepsia é a morte súbita 
em epilepsia (SUDEP). Assim, o objetivo deste artigo foi alertar a comunidade científica sobre a SUDEP.
Palavras-Chave: epilepsia, SUDEP, coração, crises epilépticas.
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believe that a policy of informing all patients will cause stress 
and anxiety13. Thus, two questions have generated more pas-
sionate discussion than any other aspect of SUDEP: should 
all people diagnosed with epilepsy be told about the possibil-
ity of SUDEP? Or should only those who are at higher risk be 
told?14,15. In general, it has been proposed that people should 
be fully informed about the risks of any condition or its treat-
ment, although there is debate about the quality and timing of 
information on SUDEP to patients and relatives13. Following 
this line of reasoning, as neuroscientists in Latin America we 
do not have a formal opinion on this matter; therefore we 
enjoyed the presence of experts on this condition in the last 
Latin American Summer School on Epilepsy (LASSE) to start 
clarifying this issue in our region16. The main question was 
designed as a multiple choice meant to cover any position 
towards SUDEP counseling16: under which conditions would 
you tell a person with epilepsy the risks of SUDEP?
a) I would never tell;
b) I would tell only if the person approached the subject;
c) I would tell to all people with epilepsy;
d) I would tell to people with higher risk factors;
e) I have never thought of this possibility.
After careful analysis, some important conclusions and 
future prospects could be established: as SUDEP is not a rare 
event, caution remains prudent and necessary; patients with 
high risk factors for epilepsy should be told about SUDEP; 
a SUDEP practice guideline via the all Leagues of Epilepsy 
in Latin America should be developed; a SUDEP task force 
should be created in Latin America to disseminate consis-
tent information regarding it for all health professionals; a 
research agenda in Latin America (experimental and clinical 
level) should be developed, and research agencies of the gov-
ernments of each Latin American country should be encour-
aged to release funds for this purpose; from these preliminary 
data, SUDEP will be deeply discussed in all subsequent edi-
tions of LASSE16.
People with refractory epilepsy may appear healthy 
during their lives, but they are more likely to die suddenly. 
Various mechanisms have been hypothesized or already 
proven to play a role in the etiology of SUDEP; however, more 
research is required to further elucidate its pathophysiology. 
Besides, if there is reason to suspect a patient’s risk, we are 
certain that a point of convergence between physicians ( fam-
ily physician, cardiologist, and specialist center) is really im-
portant, in order that together they can establish diagnosis, 
treatment options, risk determination, and counseling of the 
family members or caregivers.
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